IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma - Boyle - 2014 - Cancer - Wiley Online Library
Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma | PLOS ONE
Irene Ghobrial, MD - Home | Facebook
Immunomodulator Drug-Based Therapy in Myeloma and the Occurrence of Thrombosis
Dr. Luke Whitesell, MD – Cambridge, MA | Pediatric Hematology & Oncology
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma | PLOS ONE
Salomon Manier
Post-Congress webinars – International Academy for Clinical Hematology (IACH)
Eileen Mary BOYLE | PostDoc /MD | MD/PhD | NYU Langone Medical Center, New York City | NYUMC | Cancer Institute | Research profile
Sequencing BCMA-targeted agents in multiple myeloma | VJHemOnc
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Dr. Amir Yosef, MD | Mankato, MN | Oncologist | US News Doctors
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Dr.MHB (@DrMHB1) / Twitter
Team : Factors of persistence of leukemic cells - Canther
ASH 2022: A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial
Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia
Primary refractory young myeloma: a difficult clinical situation - YouTube
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber by Myeloma Crowd Radio | Mixcloud
Antibody-drug Conjugates in Relapsed/Refractory Multiple Myeloma: from Bench to Bedside - Springer Healthcare IME
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
Forimtamig's Effect on T-cells in Relapsed Myeloma Patients
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis
Study Shows That Immune System Holds Clues to Patients With High-Risk Smoldering Myeloma Likely to Benefit From Treatment - BroadcastMed
